Haematology and Oncology Archives - Page 4 of 19

The expanding scenario of advanced non-small-cell lung cancer between emerging evidence and clinical tasks

Andrea De Giglio, Biagio Ricciuti, Giulio Metro

Article Type

Editorial

Published

02 May 2023

This Editorial by De Giglio, Ricciuti and Metro introduces the series Treatment of advanced non-small-cell lung cancer: one size does not fit all.

Non-small-cell lung cancer: how to manage BRAF-mutated disease

Giorgia Guaitoli, Lodovica Zullo, Marcello Tiseo, Matthew Dankner, April AN Rose, Francesco Facchinetti

Article Type

Review

Published

02 May 2023

This review aims to offer a comprehensive update about available therapeutic options for patients with NSCLC harbouring BRAF mutations to guide the physician in the choice of treatment strategies.

Multidisciplinary approach, continuous care and opioid management in cancer pain: case series and review of the literature

Giampiero Porzio, Andreia Capela, Raffaele Giusti, Francesca Lo Bianco, Mirella Moro, Giulio Ravoni, Katarzyna Zułtak-Baczkowska

Article Type

Original Research

Published

11 Apr 2023

This narrative literature review emphasizes the value of providing all patients with multidisciplinary pain management in their preferred care setting. Real-life experiences are also reported to witness the efforts of physicians to properly manage cancer pain.

High-rate breakthrough cancer pain and tumour characteristics – literature review and case series

Arturo Cuomo, Anastasios Boutis, Francesca Colonese, Davide Nocerino

Article Type

Review

Published

10 Mar 2023

The aim of this narrative review is to explore the relationship between high-rate breakthrough cancer pain, which strongly impacts health-related quality of life and tumour characteristics, in the face of novel approaches that should provide guidance for future clinical practice.

HR+/HER2– de novo metastatic breast cancer:
a true peculiar entity?

Rosalba Torrisi, Flavia Jacobs, Chiara Miggiano, Rita De Sanctis, Armando Santoro

Article Type

Review

Published

06 Mar 2023

This is a critical narrative review focusing on HR+/human epidermal growth factor receptor 2-negative (HER2–) de novo metastatic breast cancer in terms of genomic, biological, pathological, and clinical features and outcomes after systemic and locoregional treatments, outlining differences with recurrent metastatic breast cancer.